INdermal presents EXO DDS Eyes360: marine biotechnology and advanced release to transform eye contour care

The new active ingredient combines marine biomimetic exosomes, encapsulated Hexapeptide-8, and DDS technology to address wrinkles, bags, and dark circles. Efficacy studies show outstanding results after 56 days of application.

02 of November of 2026
EXO DDS Eyes360

What if eye contour care could go beyond treating a single aesthetic concern? INdermal, the brand specializing in advanced cosmetic ingredients from Nanovex Biotechnologies, presents EXO DDS Eyes360, a biotechnological innovation that combines marine inspiration, peptide precision, and advanced release to comprehensively address the main signs of aging and fatigue around the eyes.

Three mechanisms, a more revitalized look

The eye contour is one of the areas of the face where the signs of aging are most visible. Expression wrinkles, bags, and dark circles respond to different biological processes that require a multifunctional approach.

EXO DDS Eyes360 brings together two key components in a single solution: a biomimetic system inspired by the molecular richness of a marine nanoplankton holobiont and Hexapeptide-8, a cosmetic peptide aimed at improving the appearance of expression lines. Both are integrated into INdermal's Deep Delivery System (DDS), designed to protect active ingredients and promote their transport and release into the skin.

The result is an ingredient conceived to go beyond conventional periocular care solutions, with a 360° approach that combines different mechanisms of action in a single formulation.

Clinical efficacy for a more rested look

 

The results obtained in an efficacy study with a formulation containing 5% EXO DDS Eyes360, applied twice a day for 56 days, show improvements in different parameters related to the appearance of the eye contour.

Among the most notable results are:

  • Up to a 69% reduction in wrinkle roughness, evaluated by 3D optical profilometry.
  • Up to a 43% reduction in the volume of subocular bags, according to individual instrumental measurements.
  • An average increase of 75% in the ITA index, associated with a clearer appearance of vascular dark circles.
  • 91% of participants perceived a more rejuvenated and healthy look after the treatment.

These results reflect the potential of EXO DDS Eyes360 to develop cosmetic treatments that address several of the main concerns of the eye contour in a single proposal.

Advanced biotechnology at the service of cosmetic formulation

With EXO DDS Eyes360, INdermal reinforces its commitment to innovation in cosmetic ingredients by combining biomimetic active ingredients and advanced delivery systems. Its versatility allows it to be incorporated into different formats, such as serums, creams, and specific treatments for the eye contour.

The innovation also has vegan certification and 99.74% natural origin, according to ISO 16128, offering formulators new possibilities to develop high added-value periocular care products.

With this launch, INdermal expands its portfolio of biotechnological solutions for the cosmetic industry, bringing advanced encapsulation technologies to a new generation of skincare formulations.